THROAT SPRAY Reduces COVID-19 Spread, Study Claims

THROAT SPRAY Reduces COVID-19 Spread, Study Claims

THROAT SPRAY Reduces COVID-19 Spread, Study Claims
Photo: Mashable SEA

A Singaporean study claims that a throat spray used to treat short-term malaria and some auto-immune diseases can reduce COVID-19 spread.

READ: Thailand to Issue COVID PASSPORTS as It Eyes Wider Reopening

The study is already in the International Journal of Infectious Diseases. They found that the said throat spray containing hydroxychloroquine is effective against COVID-19 spread. This is especially in high-risk, high-transmission settings.

During the study, experts conducted a 42-day randomized clinical trial on 3,037 healthy migrant workers quarantined in a dormitory in Singapore. 

Later on, they found that those who received hydroxychloroquine tablets and povidone-iodine throat spray have less frequent COVID-9 infection. Meanwhile, they didn’t observe real differences when they used Vitamin C as a comparator medicine.

“These existing drugs could complement existing safety measures in settings. This is especially where transmission is high while awaiting the roll-out of a vaccine,” Associate Professor Raymond Seet said in a statement.

These findings provide valuable information. It also includes observation regarding the frequency of transmission was still significantly lower; this considers previous room exposure. It also considers age group, nationalities, antibody presence in the blood (seropositivity), and drug compliance.

THROAT SPRAY Reduces COVID-19 Spread, Study Claims
Photo: Mashable SEA

Meanwhile, the study lead author said further studies could cover the effects in other populations, such as older people and women, and in those with a compromised immune system.